Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Reflections on the genetics-first approach to advancements in molecular genetic and neurobiological research on neurodevelopmental disorders
Many patients research Lipo B because they want more than a standard diet recommendation
Jutkowitz E, Kane RL, Gaugler JE, MacLehose RF, Dowd B, Kuntz KM
In fact, as of this writing, there is only one small retrospective study involving intra-articular knee injection into patients experiencing non specific knee pain
Components: GHK-Cu (glycyl-L-histidyl-L-lysine copper, copper-binding tripeptide) and BPC-157 (Body Protection Compound-157, 15-amino-acid synthetic peptide)